Thymalin
Thymalin is described in the literature as a polypeptide complex isolated from thymus tissue. Product composition and regulatory status vary by market. Mechanistic cell studies and older clinical reports do not establish a modern, product-independent efficacy or safety profile.
Pharmacokinetic model
A route-level PK model for thymalin is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Thymic Peptide Complex
- Suggested cadence
- once daily
Research behind this entry
-
Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
An in-vitro study exposed human hematopoietic stem cells to thymalin and reported changes in CD44, CD117, and CD28 expression. It did not administer thymalin to people, characterize exposure, or test a clinical outcome.
1 published study referenced in the app, each with a plain-language summary.